文献速递肾移植

首次与再次肾移植的移植物存活、患者存活及移植物功能延迟恢复的荟萃分析

A meta-analysis of graft survival, patient survival and delayed graft function in first-time and repeat kidney transplants.
PubMed 文献 · Nephrol Dial Transplant · 2025-01-01

该荟萃分析纳入16项研究,比较首次、二次及多次肾移植的移植物存活与移植物功能延迟恢复。首次移植长期移植物存活优于二次移植(86.7% vs 77.6%;OR 1.40,95%CI 1.14-1.71,P=.001),但10年时差异无统计学意义。患者总体存活在首次与二次移植间无显著差异,移植物功能延迟恢复率也无显著差异(P=.11)。

要点

  • 首次移植长期移植物存活优于二次移植(86.7% vs 77.6%;OR 1.40,95%CI 1.14-1.71,P=.001)。
  • 移植后5年首次移植移植物存活仍优(OR 1.41,95%CI 1.13-1.77,P=.003),10年时无显著差异(OR 1.26,95%CI 0.88-1.81,P=.20)。
  • 首次与二次移植患者总体存活无显著差异(OR 1.25,95%CI 0.87-1.81,P=.23),移植物功能延迟恢复率无显著差异(P=.11)。

核心结论

  • 首次和二次肾移植的移植物存活优于后续再次移植,尤其在移植后早期;各组患者总体存活无显著差异;但研究异质性和患者个体因素导致结局变异,需谨慎解读并个体化临床处理。

研究设计与样本

  • 荟萃分析,检索PubMed、Web of Science、Cochrane Library、MEDLINE(Ovid)和Scopus截至2024年10月8日,共纳入16项研究。

主要发现

  • 首次移植长期移植物存活优于二次移植(86.7% vs 77.6%;OR 1.40,95%CI 1.14-1.71,P=.001)。
  • 移植后5年首次移植移植物存活仍优(OR 1.41,95%CI 1.13-1.77,P=.003),10年时无显著差异(OR 1.26,95%CI 0.88-1.81,P=.20)。
  • 二次移植5年移植物存活显著高于三次移植(OR 2.66,95%CI 1.86-3.80,P<.00001)。
  • 首次与二次移植患者总体存活无显著差异(OR 1.25,95%CI 0.87-1.81,P=.23);5年存活率呈边缘非显著趋势 favoring 首次移植(OR 1.63,95%CI 0.97-2.73,P=.06),10年存活率无差异(OR 0.94,95%CI 0.67-1.32,P=.71)。
  • 二次与后续再次移植(如三次或四次肾移植)存活率无显著差异,包括5年(分别为P=.37和P=.90)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 研究异质性和患者个体因素导致结局变异,需谨慎解读并个体化临床处理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous evidence showed that while first-time kidney transplants (KT) typically yield better outcomes, repeat and subsequent transplants were associated with increased risks of graft failure and adverse patient outcomes, yet conflicting findings exist. The aim of this meta-analysis is to compare graft survival and delayed graft function (DGF) outcomes in first-time KT, repeat KT (regrafts) and subsequent KT. METHODS: Relevant studies were identified through comprehensive searches in PubMed, Web of Science, Cochrane Library, MEDLINE (Ovid) and Scopus until 8 October 2024. Primary outcomes include graft survival and DGF, compared with repeat and subsequent KT. RESULTS: The meta-analysis included a total of 16 studies. Analysis on long-term graft survival revealed that patients who underwent a first KT had significantly better graft survival compared with those who received a second transplant [86.7% versus 77.6%; odds ratio (OR) 1.40, 95% confidence interval (CI) 1.14-1.71, P = .001]. At 5 years post-transplant, first KT recipients continued to demonstrate superior graft survival (OR 1.41, 95% CI 1.13-1.77, P = .003), although this difference diminished by 10 years, with no significant disparity observed (OR 1.26, 95% CI 0.88-1.81, P = .20). Graft survival at 5 years was also significantly higher in second KT recipients compared with those undergoing a third transplant (OR 2.66, 95% CI 1.86-3.80, P < .00001). Patient survival outcomes were largely comparable between first and second KT groups, with no statistically significant differences in overall survival (OR 1.25, 95% CI 0.87-1.81, P = .23). At specific time points, the 5-year survival rate showed a borderline non-significant trend favoring first KT recipients (OR 1.63, 95% CI 0.97-2.73, P = .06), while the 10-year survival rate showed no difference (OR 0.94, 95% CI 0.67-1.32, P = .71). Survival rates between second and subsequent retransplants (e.g. third or fourth KT) showed no significant variation, including at 5 years (P = .37 and P = .90, respectively). DGF rates did not differ significantly between first and second KT recipients (P = .11). CONCLUSION: These findings underscore the superior graft survival associated with first and second KT compared with subsequent retransplants, particularly in the early post-transplant period, while highlighting the lack of significant differences in overall patient survival across groups; however, variability in outcomes due to study heterogeneity and patient-specific factors warrants cautious interpretation and tailored clinical approaches.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Kanbay M, Abdel-Rahman SM, Brinza C, et al. A meta-analysis of graft survival, patient survival and delayed graft function in first-time and repeat kidney transplants. Nephrol Dial Transplant. 2025. PMID: 40234207. doi:10.1093/ndt/gfaf066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。